Skip to content Skip to sidebar Skip to footer

Aurobindo Pharma Limited Latest News

Aurobindo Pharma Limited Latest News. Manufacturers and exporters of bulk drugs, formulations, and oral suspensions. Site provides product details, company profile and information to the six manufacturing facilities in india.

Aurobindo Pharma Share Price, AUROPHARMA, Live NSE/BSE, Stock Price
Aurobindo Pharma Share Price, AUROPHARMA, Live NSE/BSE, Stock Price from equitypandit.com

India's aurobindo pharma ltd learnt its director p. Aurobindo pharma limited is pleased to announce that its wholly owned subsidiary company, eugia pharma specialities limited, has received a final approval from the us food & drug. Its profit for the latest quarter stood at rs 409.45 crore, down 41.25 per cent from the same quarter a year ago.

From All Sources At A Single Place.


A pharmaceutical company is voluntarily recalling a blood pressure medication due to a potential cancer risk, federal regulators said. Food and drug administration for its abbreviated new drug application ursodiol. Aurobindo pharma's net jumps by 45% to rs 850 crore in q4.

Pharma Biggie Aurobindo Pharma Ltd (Apl), Its Promoters And Related Entities Were On Monday Slapped With A Rs 22.7 Crore Fine By Sebi For Insider Trading.


Aurobindo to acquire 60% stake in an upcoming manufacturing facility of celon laboratories limited. Aurobindo pharma gained 1.35% to rs 462.40 on bargain hunting after sliding for seven trading sessions. Sarath chandra reddy, a director of aurobindo pharma ltd, the drugmaker said in an exchange filing on thursday.

Growing Export Revenue Offers Hedge Against Repayment Of Foreign Currency Term Loans, Which Is Payable Over 4 To 5.


Aurobindo pharma's price swing today. Site provides product details, company profile and information to the six manufacturing facilities in india. Aurobindo pharma limited is pleased to announce that its wholly owned subsidiary company, eugia pharma specialities limited, has received a final approval from the us food & drug.

Aurobindo Pharma’s (Aurobindo) Q2Fy23 Performance Was Below Our Expectations On All Fronts.


Its profit for the latest quarter stood at rs 409.45 crore, down 41.25 per cent from the same quarter a year ago. The company develops, manufactures and distributes generic pharmaceuticals, branded specialty. Food and drug administration said that.

Latest And Breaking News On Aurobindo Pharma Limited.


Further to our letter dated september 6, 2022 informing about the participation in the kotak institutional equity healthcare forum 2022 on september 8, 2022, we inform you. Tnn /aug 10, 2013, 18:17 (ist) aurobindo pharma on saturday. Recovery from intraday low fall from intrday high.

Post a Comment for "Aurobindo Pharma Limited Latest News"